Much of the evidence that connexins expression or signaling are altered in models of type 2 diabetes comes from rodents; however, because Cx36 is present in human islets, this gives rise to the speculation (see e.g. [11]) that a loss of Cx36 gap junction conductance may occur in type 2 diabetes. Here, GJD2 is linked to type 2 diabetes mellitus.